Cochrane · systematic review · CD011918

Protease‐modulating matrix treatments for healing venous leg ulcers

Westby, MJ, Norman, G, Dumville, JC, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

WoundsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 20%Low 4 · 80%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Protease‐modulating matrix dressing regimen compared to any other dressing regimen for healing venous leg ulcers

Population: people with venous leg ulcers
5 questions
OutcomeEffectEvidenceStatus / GRADE
TIme to complete healing
Protease‐modulating matrix dressing regimen vs any other dressing regimen
HR 1.21 [0.74, 1.97]1 study · 100 participantsLow
Downgraded: imprecision
Proportion of participants healed ‐ short term (4‐8 weeks)
Protease‐modulating matrix dressing regimen vs any other dressing regimen
RR 0.73 [0.34, 1.58]2 studies · 207 participantsVery low
Downgraded: risk of bias, imprecision
Proportion of participants healed ‐ medium term (12 weeks)
Protease‐modulating matrix dressing regimen vs any other dressing regimen
RR 1.28 [0.95, 1.71]4 studies · 192 participantsLow
Downgraded: risk of bias, imprecision
Proportion of participants healed ‐ long term (over 24 weeks)
Protease‐modulating matrix dressing regimen vs any other dressing regimen
RR 1.06 [0.8, 1.41]1 study · 100 participantsLow
Downgraded: risk of bias, imprecision
Proportion of participants with 1 or more adverse events at 2‐12 weeks
Protease‐modulating matrix dressing regimen vs any other dressing regimen
RR 1.03 [0.75, 1.42]5 studies · 363 participantsLow
Downgraded: risk of bias, imprecision